104 related articles for article (PubMed ID: 11380453)
21. Primary structure of the factor VIII binding domain of human, porcine and rabbit von Willebrand factor.
Lavergne JM; Piao YC; Ferreira V; Kerbiriou-Nabias D; Bahnak BR; Meyer D
Biochem Biophys Res Commun; 1993 Aug; 194(3):1019-24. PubMed ID: 8352759
[TBL] [Abstract][Full Text] [Related]
22. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.
Campos M; Buchanan A; Yu F; Barbalic M; Xiao Y; Chambless LE; Wu KK; Folsom AR; Boerwinkle E; Dong JF
Blood; 2012 Feb; 119(8):1929-34. PubMed ID: 22219226
[TBL] [Abstract][Full Text] [Related]
23. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?
Shahsavarzadeh T; Javanmard SH; Saadatnia M
Eur Neurol; 2011; 66(4):243-6. PubMed ID: 21967990
[TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
[TBL] [Abstract][Full Text] [Related]
25. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
26. Interaction between VWF and FVIII in treating VWD.
Miesbach W; Berntorp E
Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439
[TBL] [Abstract][Full Text] [Related]
27. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
28. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
[TBL] [Abstract][Full Text] [Related]
29. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
[TBL] [Abstract][Full Text] [Related]
31. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.
Schneppenheim R; Lenk H; Obser T; Oldenburg J; Oyen F; Schneppenheim S; Schwaab R; Will K; Budde U
Thromb Haemost; 2004 Jul; 92(1):36-41. PubMed ID: 15213842
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.
Lavergne JM; Piao Y; Ribba AS; Girma JP; Siguret V; Piétu G; Boyer-Neumann C; Schandelong A; Bahnak BR; Meyer D
Thromb Haemost; 1993 Oct; 70(4):691-6. PubMed ID: 8115998
[TBL] [Abstract][Full Text] [Related]
33. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
Jones TR; Kao KJ; Pizzo SV; Bigner DD
Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
[TBL] [Abstract][Full Text] [Related]
34. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
[TBL] [Abstract][Full Text] [Related]
35. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
36. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
37. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain.
Hamer RJ; Koedam JA; Beeser-Visser NH; Bertina RM; Van Mourik JA; Sixma JJ
Eur J Biochem; 1987 Jul; 166(1):37-43. PubMed ID: 3109914
[TBL] [Abstract][Full Text] [Related]
38. A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele.
Peerlinck K; Eikenboom JC; Ploos Van Amstel HK; Sangtawesin W; Arnout J; Reitsma PH; Vermylen J; Briët E
Br J Haematol; 1992 Mar; 80(3):358-63. PubMed ID: 1581215
[TBL] [Abstract][Full Text] [Related]
39. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
Nishino M; Miura S; Yoshioka A; Kuwahara I; Nishimura T; Hamada K; Fukui H
Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
